Tue, February 27, 2018
Mon, February 26, 2018
Fri, February 23, 2018
Thu, February 22, 2018
Wed, February 21, 2018
Tue, February 20, 2018
Fri, February 16, 2018
Thu, February 15, 2018
Wed, February 14, 2018
Tue, February 13, 2018
Mon, February 12, 2018
Fri, February 9, 2018

David Nierengarten Maintained (ANAB) at Buy with Increased Target to $151 on, Feb 20th, 2018

  Copy link into your clipboard //stocks-investing.news-articles.net/content/201 .. th-increased-target-to-151-on-feb-20th-2018.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

- Click to Lock Slider
David Nierengarten of Wedbush, Maintained "AnaptysBio, Inc." (ANAB) at Buy with Increased Target from $142 to $151 on, Feb 20th, 2018.

David has made no other calls on ANAB in the last 4 months.



There are 2 other peers that have a rating on ANAB. Out of the 2 peers that are also analyzing ANAB, 0 agree with David's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with David


  • Yatin Suneja of "SunTrust Robinson Humphrey" Initiated at Strong Buy and Held Target at $115 on, Wednesday, November 15th, 2017
  • Biren Amin of "Jefferies" Initiated at Strong Buy and Held Target at $101 on, Thursday, November 9th, 2017